Last update 08 May 2025

BRD9 Degradation Compound 5(Dana-Farber Cancer Institute)

Overview

Basic Info

Drug Type
Proteolysis-targeting chimeras (PROTAC)
Synonyms-
Target
BRD4 x BRD7 x BRD9
Action
degraders, inhibitors
Mechanism
BRD4 degraders(Bromodomain-containing protein 4 degraders), BRD7 inhibitors(Bromodomain-containing protein 7 inhibitors), BRD9 inhibitors(Bromodomain-containing protein 9 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Neoplasms
Originator Organization
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
Active Organization-
Inactive Organization
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC44H53N7O9S2
InChIKeyWPBRCJAGSVKMMS-UHFFFAOYSA-N
CAS Registry2097509-20-9

Related

100 Clinical Results associated with BRD9 Degradation Compound 5(Dana-Farber Cancer Institute)
Login to view more data
100 Translational Medicine associated with BRD9 Degradation Compound 5(Dana-Farber Cancer Institute)
Login to view more data
100 Patents (Medical) associated with BRD9 Degradation Compound 5(Dana-Farber Cancer Institute)
Login to view more data
1
Literatures (Medical) associated with BRD9 Degradation Compound 5(Dana-Farber Cancer Institute)
15 May 2017Angewandte Chemie International EditionQ1 · CHEMISTRY
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands
Q1 · CHEMISTRY
100 Deals associated with BRD9 Degradation Compound 5(Dana-Farber Cancer Institute)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPreclinical
United States
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
18 Apr 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free